Letrozole (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Letrozole drug offered from Mylan Pharmaceuticals Inc.. This Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Letrozole |
SUBSTANCE NAME: | LETROZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-04-22 |
END MARKETING DATE: | 0000-00-00 |
Letrozole HUMAN PRESCRIPTION DRUG Details:
Item Description | Letrozole from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 2011-04-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-2071_296c58a3-acf3-40af-9dc0-4f0553a0daf2 |
PRODUCT NDC: | 0378-2071 |
APPLICATION NUMBER: | ANDA078190 |
Other LETROZOLE Pharmaceutical Manufacturers / Labelers: